SCHEMBL30984033

SCHEMBL30984033

O=Cc1ccc(OCCN2CCC(O)CC2)cc1Cl

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.55
POLB P06746 1/20 0.50
ALDH1A1 P00352 4/20 0.49
LTA4H P09960 4/20 0.46
ACHE P22303 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
LMNA P02545 1/20 0.46
MAPK1 P28482 1/20 0.46
HTT P42858 1/20 0.46
MAOB P27338 1/20 0.46
PSEN1 P49768 1/20 0.46
PSEN2 P49810 1/20 0.46
APH1B Q8WW43 1/20 0.46
NCSTN Q92542 1/20 0.46
APH1A Q96BI3 1/20 0.46
PSENEN Q9NZ42 1/20 0.46
SIGMAR1 Q99720 2/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30984021 0.93 LTA4H (0.56) KDM4EPOLBALDH1A1LTA4HHRH3
SCHEMBL30983936 0.88 MEN1 (0.50) KDM4EPOLBALDH1A1LTA4HSMN1; SMN2
SCHEMBL8909081 0.85 KDM4E (0.64) KDM4EPOLBALDH1A1LTA4HHRH3
SCHEMBL30983883 0.84 KDM4E (0.65) KDM4EPOLBALDH1A1LTA4HHRH3
SCHEMBL30983972 0.82 KDM4E (0.55) KDM4EPOLBALDH1A1LTA4HACHE
SCHEMBL5755028 0.82 KDM4E (0.71) KDM4EALDH1A1LTA4HACHEMEN1
SCHEMBL30983879 0.82 KDM4E (0.42) KDM4EPOLBALDH1A1SMN1; SMN2LMNA
SCHEMBL30984049 0.81 KDM4E (0.48) KDM4EPOLBALDH1A1ACHEHRH3
SCHEMBL1628165 0.78 ALDH1A1 (0.57) KDM4EALDH1A1HRH3SMN1; SMN2SIGMAR1
SCHEMBL30984087 0.77 KDM4E (0.44) KDM4EPOLBALDH1A1HRH3SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 WO disclosed